Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|June 21, 1996
p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomasJ Benhattar, J P Cerottini, E Saraga, et al.
Cancer Research|July 9, 1999
Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activityP Yan, J M Coindre, J Benhattar, et al.
The Journal of Pathology|February 13, 2001
Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesisP Yan, E P Saraga, H Bouzourene, et al.
International Journal of Cancer|July 4, 2001
Intratumor genetic heterogeneity in advanced human colorectal adenocarcinomaB Baisse, H Bouzourene, E P Saraga, et al.
Biotechniques|February 24, 2001
Promoter methylation analysis on microdissected paraffin-embedded tissues using bisulfite treatment and PCR-SSCPY S Bian, P Yan, M C Osterheld, et al.
The British Journal of Ophthalmology|January 24, 2008
Methylation of CpG island promoters in uveal melanomaA P Moulin, G Clément, F T Bosman, et al.
American Journal of Clinical Pathology|October 12, 2000
Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagusY S Bian, M C Osterheld, F T Bosman, et al.
Diagnostic Cytopathology|October 13, 2001
Pitfalls in TRAP assay in routine detection of malignancy in effusionsR Braunschweig, I Guilleret, F Delacrétaz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2001
p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagusY S Bian, M C Osterheld, F T Bosman, et al.
The Journal of Pathology|March 1, 1996
K-ras and p53 mutations in human colorectal aberrant crypt fociL Losi, L Roncucci, C di Gregorio, et al.
Pageof 5